Cargando…

A Retrospective Cohort Study Comparing Utilization and Costs of Biologic Therapies and JAK Inhibitor Therapy Across Four Common Inflammatory Indications in Adult US Managed Care Patients

INTRODUCTION: Biologic therapies are used to treat several inflammatory diseases, including rheumatoid arthritis (RA), psoriasis (PsO), psoriatic arthritis (PsA), and ankylosing spondylitis (AS). Data from a commercial claims database were used to evaluate utilization and cost of biologic treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chastek, Benjamin, White, John, Van Voorhis, Damon, Tang, Derek, Stolshek, Bradley S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846706/ https://www.ncbi.nlm.nih.gov/pubmed/26970958 http://dx.doi.org/10.1007/s12325-016-0312-y

Ejemplares similares

Comparison of COPD health care utilization and associated costs across patients treated with LAMA+LABA fixed-dose therapies
por: Palli, Swetha R, et al.
Publicado: (2021)

Effectiveness and Costs Among Rheumatoid Arthritis Patients Treated with Targeted Immunomodulators Using Real-World U.S. Data
por: Gharaibeh, Mahdi, et al.
Publicado: (2020)

Health Care Resource Utilization and Costs Associated with Disease Progression in Ovarian Cancer
por: Simmons, Daniel, et al.
Publicado: (2022)

JAK inhibitors and the risk of malignancy: a meta-analysis across disease indications
por: Russell, Mark D, et al.
Publicado: (2023)

An Assessment of the Cost-Utility of Therapy for Psoriasis
por: Weiss, Stefan C, et al.
Publicado: (2006)

Heterodimeric JAK-STAT Activation as a Mechanism of Persistence to JAK2 Inhibitor Therapy
por: Koppikar, Priya, et al.
Publicado: (2012)

Comparing Biologic Cost Per Treated Patient Across Indications Among Adult US Managed Care Patients: A Retrospective Cohort Study
por: Gu, Tao, et al.
Publicado: (2016)

Treatment Patterns and Annual Drug Costs of Biologic Therapies Across Indications from the Humana Commercial Database
por: Howe, Andrew, et al.
Publicado: (2014)

Healthcare Resource Utilization and Associated Costs in Patients With Systemic Lupus Erythematosus Diagnosed With Lupus Nephritis
por: Bell, Christopher F, et al.
Publicado: (2023)

Utilization, Cost, and Affordability of Antihypertensive Therapy in Bulgaria
por: Mitkova, Zornitsa, et al.
Publicado: (2021)

Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
por: Convertino, Irma, et al.
Publicado: (2023)

Myeloproliferative neoplasms: From JAK2 mutations discovery to JAK2 inhibitor therapies
por: Passamonti, Francesco, et al.
Publicado: (2011)

Common protocol for validation of the QCOVID algorithm across the four UK nations
por: Kerr, Steven, et al.
Publicado: (2022)

Antidiabetic therapy in real practice: indicators for adherence and treatment cost
por: Colombo, Giorgio L, et al.
Publicado: (2012)

US Health Resource Utilization and Cost Burden Associated with Choroideremia
por: Dong, Shaobin, et al.
Publicado: (2021)

Healthcare Utilization and Costs Among US Adolescents With Alopecia Areata
por: Ray, Markqayne, et al.
Publicado: (2022)

Association Between the Patient Driven Payment Model and Therapy Utilization and Patient Outcomes in US Skilled Nursing Facilities
por: Rahman, Momotazur, et al.
Publicado: (2022)

The relationship between capacity and utilization of nonpharmacologic therapies in the US Military Health System
por: Bolton, Rendelle, et al.
Publicado: (2022)

2747. Relative Vaccine Efficacy of High-Dose vs. Standard Dose Influenza Vaccines in Preventing Probable Influenza in a US Medicare Fee-for-Service Population
por: Paudel, Misti, et al.
Publicado: (2019)

Clinical characteristics, healthcare use, and annual costs among patients with dystrophic epidermolysis bullosa
por: Feinstein, James A., et al.
Publicado: (2022)

Suppress for Success: A JAK Inhibitor for Adjunct Therapy of Tuberculosis
por: Dorhoi, Anca
Publicado: (2015)

The Cost Utility of Nonpregnancy Laboratory Monitoring for Persons on Isotretinoin Acne Therapy
por: Borre, Ethan D., et al.
Publicado: (2023)

Quality monitoring of intellectual and developmental disabilities systems in the US: Assessing the utility and applicability of selected National Core Indicators to national and state priorities
por: Bradley, Valerie, et al.
Publicado: (2022)

The Effect of Dose Escalation on the Cost-Effectiveness of Etanercept and Adalimumab with Methotrexate Among Patients with Moderate to Severe Rheumatoid Arthritis
por: Incerti, Devin, et al.
Publicado: (2020)

Patients’ access to rare neuromuscular disease therapies varies across US private insurers
por: Margaretos, Nikoletta M., et al.
Publicado: (2022)

Use of Social Media Across US Hospitals: Descriptive Analysis of Adoption and Utilization
por: Griffis, Heather M, et al.
Publicado: (2014)

Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma
por: Leung, Henry W.C., et al.
Publicado: (2017)

Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
por: Chastek, Benjamin, et al.
Publicado: (2017)

Utilization of Current Diagnostic Indicators to Characterize Pediatric Undernutrition among US Children
por: Price, Alyssa Archdeacon, et al.
Publicado: (2020)

Obtaining Longitudinal Built Environment Data Retrospectively across 25 years in Four US Cities
por: Hirsch, Jana A., et al.
Publicado: (2016)

CMR Clinical Practice Patterns Across Four U.S. Medical Centers from 2010-2014
por: Shah, Dipan J, et al.
Publicado: (2016)

Prevalence of unrecognized myocardial scarring in patients with normal contractile function across four U.S. hospitals
por: Kim, Han W, et al.
Publicado: (2016)

Mapping LGBTQ+ Youth Resource Density Across Four High HIV Prevalence Corridors in the US
por: Sallabank, Gregory, et al.
Publicado: (2021)

A review of health utilities across conditions common in paediatric and adult populations
por: Tarride, Jean-Eric, et al.
Publicado: (2010)

Phenotypic Variation across Chromosomal Hybrid Zones of the Common Shrew (Sorex araneus) Indicates Reduced Gene Flow
por: Polly, P. David, et al.
Publicado: (2013)

Understanding non-response to cardiac resynchronisation therapy: common problems and potential solutions
por: Sieniewicz, Benjamin J., et al.
Publicado: (2018)

Indicators of the Statuses of Amphibian Populations and Their Potential for Exposure to Atrazine in Four Midwestern U.S. Conservation Areas
por: Sadinski, Walt, et al.
Publicado: (2014)

COVID-19 fatalities by zip codes and socioeconomic indicators across various U.S. regions
por: Sen-Crowe, Brendon, et al.
Publicado: (2021)

Efficacy of Combination Therapy With The JAK Inhibitor Baricitinib In The Treatment of COVID-19
por: Thoms, Brendan Lawless, et al.
Publicado: (2021)

Efficacy of Combination Therapy with the JAK Inhibitor Baricitinib in the Treatment of COVID-19
por: Thoms, Brendan L., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_eaosorir4arqum10vl6ts5hkof